imiquimod has been researched along with deoxyglucose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YJ; Huang, SW; Kao, JK; Lee, HC; Liang, SM; Shieh, JJ; Wang, ST; Wu, CY | 1 |
| Chang, SH; Chen, YJ; Chuang, KC; Huang, SW; Kao, JK; Kao, SH; Liang, SM; Shieh, JJ; Wang, HY; Wang, ST; Wu, CY | 1 |
2 other study(ies) available for imiquimod and deoxyglucose
| Article | Year |
|---|---|
Targeting aerobic glycolysis and HIF-1alpha expression enhance imiquimod-induced apoptosis in cancer cells.
Topics: Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Line, Tumor; Deoxyglucose; Drug Therapy, Combination; Gene Expression Regulation; Gene Silencing; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imiquimod; Keratinocytes; Lactams, Macrocyclic; Melanoma; Mice; Protein Biosynthesis; Protein Transport; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Toll-Like Receptor 7; Toll-Like Receptor 8; Transcription, Genetic; Up-Regulation | 2014 |
Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxyglucose; Drug Synergism; Glycolysis; Humans; Imiquimod; Immunogenic Cell Death; Male; Melanoma, Experimental; Mice; Skin Neoplasms | 2020 |